Emery Pharma Attending 2018 J.P. Morgan 36th Annual Healthcare Conference

By December 5, 2017

ALAMEDA, CA. —Today, Emery Pharma, a privately owned full-service contract research laboratory, specializing in analytical chemistry, microbiology & cell biology testing, medicinal chemistry, and general R&D Support, has announced that Ron Najafi, Ph.D., CEO of Emery Pharma, will be available to meet throughout the week of the 2018 JP Morgan Conference, held on January 7-10, 2018 in San Francisco, California. During the week of the JP Morgan conference, our team will be able to respond to questions and to participate in one-on-one meetings with attendees of the conference.

Emery Pharma is available to meet during the times below:

  • Sunday, Jan. 7, 2018: 2:00 PM-5:30 PM
  • Monday, Jan. 8, 2018: 8:30 AM-6:00 PM
  • Tuesday, Jan. 9, 2018: 8:30 AM-6:00 PM
  • Wednesday, Jan. 10, 2018: 8:30 AM-6:00 PM

For more information or if you would like to schedule a meeting, please contact:

Neeku Mahdavian, +1 510-899-8825
neeku@emerypharma.com 

About Emery Pharma

Emery Pharma is an FDA registered, DEA licensed and GLP/GMP compliant contract research and development organization focused on supporting mid-size biotech, pharma with their pre-clinical projects. The team at Emery Pharma is experienced in drug discovery/medicinal chemistry, method development (pharmaceutical and biological) and validation, dissolution testing, non-clinical dose formulation and analysis, pharmaceutical impurity isolation and characterization (ID), short/long-term stability testing, discovery modeling and testing, drug candidate selection, nutraceutical and natural products. Emery Pharma’s scientists bring forth extensive experience in medical device intellectual property prosecution, litigation support and have provided technical and legal support through consultation for hundreds of patent challenges worldwide. Emery Pharma has significant expertise in complex NMR analysis and offers GMP NMR. Additionally, Emery Pharma supports PK bioanalytical analysis of API and metabolites using LCMS/MS (triple quad). Emery Pharma prides itself on helping solve tough problems and adding value to the client’s projects.

Stay connected with Emery Pharma:

Contact us at: +1-510-899-8814 or  1-888-98-EMERY

Emery Pharma’s website: https://emerypharma.com/contact/
Like us on Facebook
Follow us on Twitter
Connect with Emery Pharma on LinkedIn